Xerium Technologies (XRM) 8.17 $XRM Xerium Technologies

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Xerium Technologies (XRM) 8.17 $XRM

Xerium Technologies Has Returned 43.9% Since SmarTrend Recommendation (XRM)
Comtex SmarTrend(R) - Tue Aug 30, 12:48AM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on May 6th, 2016 at $5.94. In approximately 4 months, Xerium Technologies has returned 43.89% as of today's recent price of $8.54.
XRM: 8.17 (+0.05)

Shares of XRM Up 44.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Aug 22, 1:00PM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on May 6th, 2016 at $5.94. In approximately 4 months, Xerium Technologies has returned 44.23% as of today's recent price of $8.56.
XRM: 8.17 (+0.05)

37.8% Return Seen to Date on SmarTrend Xerium Technologies Call (XRM)
Comtex SmarTrend(R) - Fri Aug 12, 1:16PM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on May 6th, 2016 at $5.94. In approximately 3 months, Xerium Technologies has returned 37.83% as of today's recent price of $8.18.
XRM: 8.17 (+0.05)

Xerium Announces Closing of Senior Secured Notes Offering and Refinancing Transaction
BusinessWire - Tue Aug 09, 12:37PM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, today announced the closing of its $480 million in aggregate principal amount of 9.500% Senior Secured Notes due 2021 (the "Notes", which were sold at a price equal to 98.540% of their face value only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act" and to non-U.S. persons pursuant to Regulation S under the Securities Act.
XRM: 8.17 (+0.05)

Uptrend Call Working As Xerium Technologies Stock Rises 24.3% (XRM)
Comtex SmarTrend(R) - Fri Aug 05, 12:56AM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on May 6th, 2016 at $5.94. In approximately 3 months, Xerium Technologies has returned 24.35% as of today's recent price of $7.38.
XRM: 8.17 (+0.05)

Xerium Reports Q2 2016 Results
BusinessWire - Tue Aug 02, 3:15PM CDT
--Q2 2016 Sales of $124.0 million compared to $123.1 in the prior-year; up 6.1% sequentially on constant currency basis. Repositioning efforts starting to take traction.
XRM: 8.17 (+0.05)

Xerium Technologies Shares Up 30.3% Since SmarTrend's Buy Recommendation (XRM)
Comtex SmarTrend(R) - Thu Jul 28, 1:18PM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on May 6th, 2016 at $5.94. In approximately 3 months, Xerium Technologies has returned 30.33% as of today's recent price of $7.74.
XRM: 8.17 (+0.05)

Xerium Introduces Impulse Shoe Press Belt Technology
BusinessWire - Thu Jun 09, 3:15PM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, recently launched the new Impulse family of shoe press belt technology.
XRM: 8.17 (+0.05)

Xerium Technologies Has Returned 24.0% Since SmarTrend Recommendation (XRM)
Comtex SmarTrend(R) - Wed Jun 08, 1:56PM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on May 6th, 2016 at $5.94. In approximately 1 month, Xerium Technologies has returned 24.01% as of today's recent price of $7.36.
XRM: 8.17 (+0.05)

Xerium to Acquire J.J. Plank Corporation, Maker of Spencer Johnston Spreader Rolls, Advancing Strategy in High-Growth Market Segments
BusinessWire - Wed May 04, 3:41PM CDT
--Diversifies customer base into tissue embossing, flexible packaging and nonwoven production
XRM: 8.17 (+0.05)

Xerium Announces New Rolls & Services Plant in Concepcion, Chile
BusinessWire - Tue Apr 26, 4:16PM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, announced plans to establish a new roll cover and mechanical services facility located in Concepcion, Chile. The Company is continuing to reposition assets from low-growth to high-growth markets. This new project is very capital efficient in that the Company already owns the majority of the equipment that will be installed in the new Concepcion plant. The remaining spend will cross 2 calendar years and is already included in the capex guidance previously given by the Company.
XRM: 8.17 (+0.05)

Xerium Schedules First Quarter 2016 Earnings Conference Call
BusinessWire - Tue Apr 19, 3:15PM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, today announced that it plans to release its financial results for the first quarter of 2016 after the close of regular market trading on Wednesday, May 4, 2016.
XRM: 8.17 (+0.05)

Clearwater Paper Adds Two New Board Members
BusinessWire - Fri Apr 01, 5:30AM CDT
Clearwater Paper Corporation (NYSE:CLW) today announced that John P. O'Donnell and Alexander Toeldte have been appointed to the company's board of directors, effective immediately.
CLW: 63.24 (+0.49), XRM: 8.17 (+0.05), NP: 80.73 (-0.34)

Xerium Technologies Shares Down 24.1% Since SmarTrend's Sell Call (XRM)
Comtex SmarTrend(R) - Thu Mar 31, 12:48AM CDT
SmarTrend identified a Downtrend for Xerium Technologies (NYSE:XRM) on March 16th, 2016 at $7.00. In approximately 2 weeks, Xerium Technologies has returned 24.14% as of today's recent price of $5.31.
XRM: 8.17 (+0.05)

Shares of XRM Down 29.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 04, 3:45PM CST
SmarTrend identified a Downtrend for Xerium Technologies (NYSE:XRM) on November 13th, 2015 at $12.27. In approximately 3 months, Xerium Technologies has returned 29.80% as of today's recent price of $8.61.
XRM: 8.17 (+0.05)

Shares of XRM Down 31.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 04, 1:14PM CST
SmarTrend identified a Downtrend for Xerium Technologies (NYSE:XRM) on November 13th, 2015 at $12.27. In approximately 3 months, Xerium Technologies has returned 31.27% as of today's recent price of $8.43.
XRM: 8.17 (+0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 342

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 44

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 13

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading